skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 163  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Success Story of LDL Cholesterol Lowering
Material Type:
Article
Add to My Research

The Success Story of LDL Cholesterol Lowering

Circulation research, 2016-02, Vol.118 (4), p.721-731 [Peer Reviewed Journal]

2016 American Heart Association, Inc. ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.115.306297 ;PMID: 26892969

Full text available

2
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Material Type:
Article
Add to My Research

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European heart journal, 2020-01, Vol.41 (1), p.111-188 [Peer Reviewed Journal]

The European Society of Cardiology and the European Atherosclerosis Association 2019. All rights reserved. For permissions please email: journals.permissions@oup.com. 2019 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz455 ;PMID: 31504418

Full text available

3
Cognitive Function in a Randomized Trial of Evolocumab
Material Type:
Article
Add to My Research

Cognitive Function in a Randomized Trial of Evolocumab

The New England journal of medicine, 2017-08, Vol.377 (7), p.633-643 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1701131 ;PMID: 28813214

Full text available

4
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978

Full text available

5
Inflammatory and Cholesterol Risk in the FOURIER Trial
Material Type:
Article
Add to My Research

Inflammatory and Cholesterol Risk in the FOURIER Trial

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.131-140 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034032 ;PMID: 29530884

Full text available

6
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
Material Type:
Article
Add to My Research

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

The Lancet (British edition), 2022-09, Vol.400 (10355), p.832-845 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01545-8 ;PMID: 36049498

Full text available

7
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Material Type:
Article
Add to My Research

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.911-921 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2017 American College of Cardiology Foundation ;Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 28, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.11.070 ;PMID: 28231942

Full text available

8
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
Material Type:
Article
Add to My Research

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

European journal of heart failure, 2019-10, Vol.21 (10), p.1279-1287 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1596 ;PMID: 31523904

Digital Resources/Online E-Resources

9
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.2961-2970 [Peer Reviewed Journal]

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;2019. American College of Cardiology Foundation ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.513 ;PMID: 31196453

Full text available

10
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
Material Type:
Article
Add to My Research

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

European journal of heart failure, 2019-10, Vol.21 (10), p.1270-1278 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1536 ;PMID: 31584231

Digital Resources/Online E-Resources

11
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Material Type:
Article
Add to My Research

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

The American heart journal, 2016-03, Vol.173, p.94-101 [Peer Reviewed Journal]

Mosby, Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2016 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2015.11.015 ;PMID: 26920601

Full text available

12
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Material Type:
Article
Add to My Research

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

The Lancet (British edition), 2010-02, Vol.375 (9716), p.735-742 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 27-Mar 5, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61965-6 ;PMID: 20167359 ;CODEN: LANCAO

Full text available

13
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Material Type:
Article
Add to My Research

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Circulation (New York, N.Y.), 2020-05, Vol.141 (20), p.1600-1607 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.046397 ;PMID: 32223429

Full text available

14
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
Material Type:
Article
Add to My Research

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

European heart journal, 2015-06, Vol.36 (24), p.1536-1546 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com. ;The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. 2015 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehv072 ;PMID: 25802390

Full text available

15
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects ― A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects ― A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial

Circulation Journal, 2021/10/25, Vol.85(11), pp.2063-2070 [Peer Reviewed Journal]

2021, THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-20-1051 ;PMID: 33980763

Full text available

16
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
Material Type:
Article
Add to My Research

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)

The Lancet (British edition), 2004-08, Vol.364 (9436), p.771-777 [Peer Reviewed Journal]

2004 Elsevier Ltd ;2004 INIST-CNRS ;Copyright Lancet Ltd. Aug 28-Sep 3, 2004 ;Copyright Elsevier Limited Aug 28, 2004 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(04)16936-5 ;PMID: 15337403 ;CODEN: LANCAO

Full text available

17
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
Material Type:
Article
Add to My Research

High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease

Heart (British Cardiac Society), 2015-03, Vol.101 (5), p.356-362 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2014-306906 ;PMID: 25595417

Full text available

18
Dynamic path analysis - a useful tool to investigate mediation processes in clinical survival trials
Material Type:
Article
Add to My Research

Dynamic path analysis - a useful tool to investigate mediation processes in clinical survival trials

Statistics in medicine, 2015-12, Vol.34 (29), p.3866-3887 [Peer Reviewed Journal]

Copyright © 2015 John Wiley & Sons, Ltd. ;ISSN: 0277-6715 ;EISSN: 1097-0258 ;DOI: 10.1002/sim.6598 ;PMID: 26278111 ;CODEN: SMEDDA

Full text available

19
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
Material Type:
Article
Add to My Research

Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study

PloS one, 2016-04, Vol.11 (4), p.e0153440-e0153440 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Ikdahl et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;2016 Ikdahl et al 2016 Ikdahl et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0153440 ;PMID: 27093159

Full text available

20
Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Material Type:
Article
Add to My Research

Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

Journal of the American Heart Association, 2016-06, Vol.5 (6), p.n/a [Peer Reviewed Journal]

2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.003407 ;PMID: 27329448

Full text available

Results 1 - 20 of 163  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (151)

Refine My Results

Creation Date 

From To
  1. Before 1995  (7)
  2. 1995 To 2000  (23)
  3. 2001 To 2006  (19)
  4. 2007 To 2013  (40)
  5. After 2013  (74)
  6. More options open sub menu

Language 

  1. Japanese  (25)
  2. Russian  (2)
  3. Norwegian  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait